Evidence map›Paper›PMID 35678017›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2022

Feasibility of a best-worst scaling exercise to set priorities for autism research.

Scott A Davis, Kirsten Howard, Alan R Ellis, Daniel E Jonas, Timothy S Carey, Joseph P Morrissey, Kathleen C Thomas

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Feasibility of a best-worst scaling exercise to set priorities for autism research.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Scott A DavisDivision of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Asheville, North Carolina, USA.ORCID 0000-0001-6593-9850
Kirsten HowardFaculty of Medicine and Health, School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Alan R EllisDepartment of Sociology, North Carolina State University, Raleigh, North Carolina, USA.
Daniel E JonasDepartment of Internal Medicine, Ohio State University Medical Center, Columbus, Ohio, USA.
Timothy S CareyDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Joseph P MorrisseyDepartment of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Kathleen C ThomasDivision of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Asheville, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe preferences of autism stakeholders regarding the top priorities for future autism research are largely unknown.

objectiveThis study had two objectives: First, to examine what autism stakeholders think new research investments should be and the attributes of investment that they consider important, and second, to explore the feasibility, acceptability and outcomes of two prioritization exercises among autism stakeholders regarding their priorities for future research in autism.

designThis was  a prospective stakeholder-engaged iterative study consisting of best-worst scaling (BWS) and direct prioritization exercise. SETTING AND

participantsA national snowball sample of 219 stakeholders was included: adults with autism, caregivers, service providers and researchers.

main outcome measuresThe main outcomes measures were attributes that participants value in future research investments, and priority research investments for future research.

resultsTwo hundred and nineteen participants completed the exercises, of whom 11% were adults with autism, 58% were parents/family members, 37% were service providers and 21% were researchers. Among stakeholders, the BWS exercises were easier to understand than the direct prioritization, less frequently skipped and yielded more consistent results. The proportion of children with autism affected by the research was the most important attribute for all types of stakeholders. The top three priorities among future research investments were (1) evidence on which child, family and intervention characteristics lead to the best/worst outcomes; (2) evidence on how changes in one area of a child's life are related to changes in other areas; and (3) evidence on dietary interventions. Priorities were similar for all stakeholder types.

conclusionsThe values and priorities examined here provide a road map for investigators and funders to pursue autism research that matters to stakeholders. PATIENT OR PUBLIC CONTRIBUTION: Stakeholders completed a BWS and direct prioritization exercise to inform us about their priorities for future autism research.

Indexed as

Autistic DisorderBiomedical ResearchHealth PrioritiesAdultCaregiversChildFeasibility StudiesHumansParentsProspective Studiesautismbest-worst scalingdirect prioritizationdiscrete-choice experimentstakeholder engagementstakeholder priorities

Identifiers

PMID35678017
PMCPMC9327819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.